Nobel Prize in Medicine Honors Science of Controlling Brain Cells With Light
This year's Nobel Prize in Medicine went to three scientists for developing optogenetics, a technique that uses light to control neurons. The method could pave the way for new treatments for conditions such as dementia, depression and certain forms of blindness.
The Nobel Prize in Medicine was announced Monday, awarded to US psychiatrist and neurologist Karl Deisseroth along with German researchers Peter Hegemann and Georg Nagel. The trio was recognized for their pioneering contributions to the neuroscience field known as optogenetics.
What Optogenetics Does
Optogenetics is a scientific method that allows researchers to control neurons by stimulating them with light. This approach gives scientists a precise tool for studying how the brain functions at the cellular level.
Potential Medical Applications
The technique is seen as holding significant promise for advancing treatment of serious conditions, including dementia, depression and some forms of blindness. By enabling more targeted observation and manipulation of specific neurons, the discovery opens the door to future therapeutic breakthroughs.
The Nobel committee's decision underscores how using light to influence brain cell activity has become one of the most important advances in neuroscience in recent decades, giving researchers a powerful new instrument for exploring brain processes.
/nginx/o/2025/10/07/17194845t1h6142.png)
